The World Health Organization (WHO) has reached a pivotal moment in the fight against COVID-19 by prequalifying the first two rapid antigen diagnostic tests for SARS-CoV-2. This groundbreaking ...

In a significant development in the fight against COVID-19, the World Health Organization (WHO) has prequalified two rapid antigen tests for detecting the virus. This landmark decision, announced last ...

COVID-19 vaccination before or during pregnancy was linked to lower risk for severe maternal disease in the delta or omicron variant periods, ...

As COVID completes its sixth year, official statistics obscure the scale of harm, while Long COVID and excess deaths reveal ...

More than two years after the World Health Organization (WHO) declared an end to the emergency phase of the Covid-19 pandemic ...

The assay is the first to receive FDA 510(k) clearance and CLIA waiver for use with Diasorin's Liaison Nes platform.

The SD Biosensor Standard Q COVID-19 Ag Test and Acon Biotech Flowflex SARS-CoV-2 Antigen Rapid Test were previously listed under WHO's emergency use listing.

In September 2020, the SD Biosensor STANDARD Q COVID-19 Ag Test became the first rapid antigen test ever listed under WHO’s ...

WHO noted that prequalified tests can now be prioritized in pooled procurement mechanisms, which help lower prices, stabilize ...

Long COVID—defined as symptoms persisting ≥ 2 months beyond acute SARS-CoV-2 infection without alternative explanation—now ...

SD Biosensor STANDARD Q and ACON Flowflex—after their earlier emergency use during the pandemic. The move confirms long-term ...

Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...